149 related articles for article (PubMed ID: 35435193)
41. Long-pulsed Nd: YAG laser (1064 nm) versus intralesional botulinum toxin type (A) in acne vulgaris therapy: a split face study.
Ibrahim AM; Omar GAB; Hamdino M
Int J Dermatol; 2023 Jun; 62(6):822-830. PubMed ID: 36468835
[TBL] [Abstract][Full Text] [Related]
42. Therapeutic effects of a new invasive pulsed-type bipolar radiofrequency for facial erythema associated with acne vulgaris and rosacea.
Jung YJ; Ro YS; Ryu HJ; Kim JE
J Cosmet Laser Ther; 2020 Jul; 22(4-5):205-209. PubMed ID: 33650938
[TBL] [Abstract][Full Text] [Related]
43. Evaluation of 30% supramolecular salicylic acid followed by 1565-nm non-ablative fractional laser on facial acne and subsequent enlarged pores.
Han Q; Zeng J; Liu Y; Yin J; Sun P; Wu Y
Lasers Med Sci; 2023 Mar; 38(1):91. PubMed ID: 36947275
[TBL] [Abstract][Full Text] [Related]
44. A randomized, split-face clinical trial of low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser versus low-fluence Q-switched alexandrite laser (755 nm) for the treatment of facial melasma.
Fabi SG; Friedmann DP; Niwa Massaki AB; Goldman MP
Lasers Surg Med; 2014 Sep; 46(7):531-7. PubMed ID: 24895301
[TBL] [Abstract][Full Text] [Related]
45. Comparison of novel dual mode vs conventional single pass of a 1450-nm diode laser in the treatment of acne vulgaris for Korean patients: A 20-week prospective, randomized, split-face study.
Kwon HH; Choi SC; Jung JY; Bae YI; Park GH
J Cosmet Dermatol; 2018 Dec; 17(6):1063-1068. PubMed ID: 30225903
[TBL] [Abstract][Full Text] [Related]
46. An in vivo model of postinflammatory hyperpigmentation and erythema: clinical, colorimetric and molecular characteristics.
Vellaichamy G; Kohli I; Zubair R; Yin C; Braunberger T; Nahhas AF; Nicholson C; Mohammad TF; Isedeh P; Lyons AB; Nartker N; Al-Jamal M; Matsui M; Karaman-Jurukovska N; Zhou L; Lim HW; Mi QS; Hamzavi IH
Br J Dermatol; 2022 Mar; 186(3):508-519. PubMed ID: 34625951
[TBL] [Abstract][Full Text] [Related]
47. BPX-01 Minocycline Topical Gel Shows Promise for the Treatment of Moderate-to-severe Inflammatory Acne Vulgaris.
Alexis A; Del Rosso JQ; Desai SR; Downie JB; Draelos ZD; Feser C; Forconi R; Fowler JF; Gold M; Kaufman-Janette J; Lain E; Lee M; Ling M; Shamban AT; Werschler WP; Daniels A
J Clin Aesthet Dermatol; 2018 Nov; 11(11):25-35. PubMed ID: 30588271
[No Abstract] [Full Text] [Related]
48. Clinical evaluation of efficacy of intralesional platelet-rich plasma injection versus 1064 nm long-pulsed Neodymium:YAG laser in the treatment of inflammatory acne vulgaris in adolescent and post-adolescent patients: a prospective randomized split-face comparative study.
Moftah NH; Mansour AM; Ibrahim SMA
Lasers Med Sci; 2022 Jul; 37(5):2471-2478. PubMed ID: 35084634
[TBL] [Abstract][Full Text] [Related]
49. Tranexamic acid versus fractional carbon dioxide laser in post-acne hyperpigmentation.
Tawfic SO; Abdel Hay R; Salim H; Elmasry MF
Dermatol Ther; 2021 Nov; 34(6):e15103. PubMed ID: 34414642
[TBL] [Abstract][Full Text] [Related]
50. The long-term effect of 1550 nm erbium:glass fractional laser in acne vulgaris.
Liu Y; Zeng W; Hu D; Jha S; Ge Q; Geng S; Xiao S; Hu G; Wang X
Lasers Med Sci; 2016 Apr; 31(3):453-7. PubMed ID: 26796708
[TBL] [Abstract][Full Text] [Related]
51. Therapeutic efficacy of metronidazole by needle-free jet injection combined with blue light therapy in Moderate-to-Severe facial acne vulgaris.
Yi L; Gao L; Lv L; Zhang B; Chen F; Yang F; Yan W; Jiang L; Li N; Lao Y; Lu J; Huang X
J Cosmet Dermatol; 2023 Feb; 22(2):569-576. PubMed ID: 36208057
[TBL] [Abstract][Full Text] [Related]
52. Acne erythema improvement by long-pulsed 595-nm pulsed-dye laser treatment: a pilot study.
Yoon HJ; Lee DH; Kim SO; Park KC; Youn SW
J Dermatolog Treat; 2008; 19(1):38-44. PubMed ID: 18273723
[TBL] [Abstract][Full Text] [Related]
53. Application of plasma-combined regeneration technology in managing facial acne scars.
Tian J; Lei XX; Xuan L; Tang JB; Cheng B
J Cosmet Laser Ther; 2019; 21(3):138-144. PubMed ID: 30110184
[TBL] [Abstract][Full Text] [Related]
54. Treatment of inflammatory facial acne vulgaris: comparison of the 1450-nm diode laser and conventional physical treatment.
Maruguchi Y; Maruguchi T
J Cosmet Laser Ther; 2006 Dec; 8(4):167-9. PubMed ID: 19839168
[TBL] [Abstract][Full Text] [Related]
55. Clinical and Histological Effects of Topical Epidermal Growth Factor on Acne and Acne Scars.
Kim DH; Yang JH; Cho SI; Yoon JY; Kim JW; Choi S; Suh DH
Dermatology; 2022; 238(5):837-845. PubMed ID: 35078198
[TBL] [Abstract][Full Text] [Related]
56. Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Impact of Gender and Race on Efficacy and Safety.
Lain E; Day D; Harper J; Guenin E
J Drugs Dermatol; 2019 Nov; 18(11):1128-1138. PubMed ID: 31741356
[TBL] [Abstract][Full Text] [Related]
57. Clinical evaluation of a 1,450-nm diode laser as adjunctive treatment for refractory facial acne vulgaris.
Astner S; Tsao SS
Dermatol Surg; 2008 Aug; 34(8):1054-61. PubMed ID: 18462424
[TBL] [Abstract][Full Text] [Related]
58. Treatment of pigmentary disorders in patients with skin of color with a novel 755 nm picosecond, Q-switched ruby, and Q-switched Nd:YAG nanosecond lasers: A retrospective photographic review.
Levin MK; Ng E; Bae YS; Brauer JA; Geronemus RG
Lasers Surg Med; 2016 Feb; 48(2):181-7. PubMed ID: 26922302
[TBL] [Abstract][Full Text] [Related]
59. Long-pulsed dye laser versus long-pulsed dye laser-assisted photodynamic therapy for acne vulgaris: A randomized controlled trial.
Haedersdal M; Togsverd-Bo K; Wiegell SR; Wulf HC
J Am Acad Dermatol; 2008 Mar; 58(3):387-94. PubMed ID: 18280335
[TBL] [Abstract][Full Text] [Related]
60. Once-Daily Oral Sarecycline 1.5 mg/kg/day Is Effective for Moderate to Severe Acne Vulgaris: Results from Two Identically Designed, Phase 3, Randomized, Double-Blind Clinical Trials.
Moore A; Green LJ; Bruce S; Sadick N; Tschen E; Werschler P; Cook-Bolden FE; Dhawan SS; Forsha D; Gold MH; Guenthner S; Kempers SE; Kircik LH; Parish JL; Rendon MI; Rich P; Stein-Gold L; Tyring SK; Weiss RA; Nasir A; Schmitz C; Boodhoo TI; Kaoukhov A; Berk DR
J Drugs Dermatol; 2018 Sep; 17(9):987-996. PubMed ID: 30235387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
